GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » Equity-to-Asset

Procaps Group (Procaps Group) Equity-to-Asset : 0.08 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Procaps Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Procaps Group's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $39.4 Mil. Procaps Group's Total Assets for the quarter that ended in Sep. 2023 was $498.6 Mil. Therefore, Procaps Group's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.08.

The historical rank and industry rank for Procaps Group's Equity-to-Asset or its related term are showing as below:

PROC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.72   Med: -0.02   Max: 0.08
Current: 0.08

During the past 4 years, the highest Equity to Asset Ratio of Procaps Group was 0.08. The lowest was -0.72. And the median was -0.02.

PROC's Equity-to-Asset is ranked worse than
86.38% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs PROC: 0.08

Procaps Group Equity-to-Asset Historical Data

The historical data trend for Procaps Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group Equity-to-Asset Chart

Procaps Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
-0.72 -0.71 -0.08 -

Procaps Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 - 0.01 0.07 0.08

Competitive Comparison of Procaps Group's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procaps Group's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Procaps Group's Equity-to-Asset falls into.



Procaps Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Procaps Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-0.941/460.187
=-0.00

Procaps Group's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=39.386/498.554
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procaps Group  (NAS:PROC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Procaps Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Procaps Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Procaps Group (Procaps Group) Business Description

Traded in Other Exchanges
Address
9 Rue de Bitbourg, Luxembourg, LUX, L-1273
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Executives
Alexandre Weinstein Manieu director, 10 percent owner CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski director, 10 percent owner, officer: Chief Executive Officer 9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski director, 10 percent owner 9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust 10 percent owner OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust 10 percent owner 29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust 10 percent owner 29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a. 10 percent owner 3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371